Newly curated references since 2025-06-07 |
---|
Reference | Species | Genes Addressed |
---|
Abo El-Souad SMS, et al. (2025) Investigating endophytic fungi of Calotropis procera for novel bioactive compounds: molecular docking and bioactivity insights. Microb Cell Fact 24(1):101
| C. albicans | |ALS2 |
Abou-Chakra N, et al. (2025) Exponential Clonal Expansion of 5-Fluorocytosine-Resistant Candida tropicalis and New Insights into Underlying Molecular Mechanisms. Emerg Infect Dis 31(5):977-985
|
Amann V, et al. (2025) Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options. Pharmaceuticals (Basel) 18(4)
| C. albicans | |FCA1 |FCY2 |
Badrane H, et al. (2025) Regulation of phosphatidylinositol-(4,5)-bisphosphate and active-Rho1p levels and distribution is crucial for correct spatio-temporal cytokinesis and echinocandin responses in Candida albicans. Antimicrob Agents Chemother :e0190024
| C. albicans | |ACT1 |INP51 |IRS4 |MKC1 |MYO1 |RHO1 |
Dubey P, et al. (2025) Seo1p, a high affinity, plasma membrane transporter of the gamma-Glu-met dipeptide in yeasts and fungi. J Biol Chem :108539
| C. albicans | |SEO1 |
| C. auris | |SEO1 |
Franconi I, et al. (2025) The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis. JAC Antimicrob Resist 7(3):dlaf051
| C. parapsilosis | |MRR1 |
Gao D, et al. (2025) Synthesis of 2-Amino-4, 5-Diarylthiazole Derivatives and Evaluation of Their Anti-Candida Albicans Activity. Molecules 30(7)
| C. albicans | |ERG11 |HSP90 |YCK2 |
Lanze CE, et al. (2025) Proximity labeling identification of plasma membrane eisosome proteins in Candida albicans. Genetics
| C. albicans | |BOI2 |C1_11930W_A |C3_07580W_A |C4_06710W_A |C5_01070C_A |EIS1 |KER1 |MDG1 |MSC3 |RTA3 |SEG1 |SRD1 |SUR7 |TSA1 |
Murillo MI, et al. (2025) Evaluation of the Antifungal Properties of Azomethine-Pyrazole Derivatives from a Structural Perspective. ChemistryOpen :e202500132
| C. albicans | |ERG11 |
Shaban S, et al. (2025) Anti-virulence and anti-efflux pump activity of synthetic defensins and histatin in Candida auris. Microb Pathog :107644
| C. auris | |CDR1 |CDR2 |MDR1 |PGA26 |PGA52 |SAP3 |SNQ2 |
Sharma V, et al. (2025) Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary-Care Hospital in North India. Mycoses 68(5):e70062
| C. parapsilosis | |CDR1 |ERG11 |MDR1 |
Yadav CS, et al. (2025) Synthesis, characterization and bio-evaluation of novel series of pyrazoline derivatives as potential antifungal agents. Sci Rep 15(1):14752
| C. albicans | |DFR1 |NMT1 |
Zhao H, et al. (2025) Effects of Ire1 gene on virulence and pathogenicity of Candida albicans. Open Life Sci 20(1):20221062
| C. albicans | |IRE1 |
Srivastava V and Ahmad A (2020) Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol. PLoS One 15(5):e0233102
| C. auris | |PGA26 |PGA52 |